Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Non Operating Income (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Non Operating Income for 12 consecutive years, with $5.2 million as the latest value for Q1 2026.

  • For Q1 2026, Non Operating Income rose 10117.65% year-over-year to $5.2 million; the TTM value through Mar 2026 reached $5.7 million, down 46.07%, while the annual FY2025 figure was $527000.0, 96.07% down from the prior year.
  • Non Operating Income hit $5.2 million in Q1 2026 for Wave Life Sciences, up from $234000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $6.3 million in Q4 2024 and bottomed at -$290000.0 in Q4 2022.
  • Average Non Operating Income over 5 years is $1.5 million, with a median of $868000.0 recorded in 2022.
  • Year-over-year, Non Operating Income crashed 125.87% in 2022 and then skyrocketed 10117.65% in 2026.
  • Wave Life Sciences' Non Operating Income stood at -$290000.0 in 2022, then surged by 936.55% to $2.4 million in 2023, then skyrocketed by 159.11% to $6.3 million in 2024, then tumbled by 96.28% to $234000.0 in 2025, then skyrocketed by 2126.92% to $5.2 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $5.2 million, $234000.0, and $324000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.